Wooi Fang Lim

6PUBLICATIONS
45CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsElectrical energy storageElectrical energy generation (incl. renewables, excl. photovoltaics)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 06, 2023
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.

Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti

|Jul 12, 2022
An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides.

Ysobel R Baker, Cameron Thorpe, Jinfeng Chen

|Dec 17, 2021
Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Ghulam Hassan Dar, Cláudia C Mendes, Wei-Li Kuan

|Nov 19, 2021
GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Ghulam Hassan Dar, Cláudia C Mendes, Wei-Li Kuan

|Aug 21, 2021
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.

Wooi F Lim, Mitra Forouhan, Thomas C Roberts

|Aug 14, 2021
Dystrophin involvement in peripheral circadian SRF signalling.

Corinne A Betts, Aarti Jagannath, Tirsa LE van Westering

Pageof 1

Frequent Collaborators

4 joint publications

Matthew J A Wood

3 joint publications

Thomas C Roberts

3 joint publications

Alfina A Speciale

2 joint publications

Imre Mäger